New York, NY – Dr. Robert D. McMullen, a Mt. Kisco-based Transcranial Magnetic Stimulation (TMS) specialist and psychiatrist with decades of experience in the greater medical treatment industry, this week excitedly announced he has discovered a treatment for an incredibly rare disorder: Persistent Genital Arousal Disorder (PGAD).
Previously referred to as the Persistent Sexual Arousal Syndrome (PSAS), Weiss Disease, and even Restless Genital Syndrome (ReGS or RGS), PGAD results in spontaneous, persistent, and uncontrollable genital arousal, with or without orgasm or genital engorgement, unrelated to any feelings of sexual desire. As a result, the person living with PGAD is usually unable to sustain a job or any kind of relationship.
“PGAD, though rare, is an incredibly debilitating disease that makes it virtually impossible for the afflicted to carry on their life with any kind of normalcy,” said Dr. McMullen. “Until this week, there was never a significant treatment for PGAD, a very constricting disorder. As of today, I am proud to announce an effective treatment for the rare disease.”
Dr. Sandra Leiblum first documented PGAD in 2001. Only recently was it characterized as a distinct syndrome in medical literature with a comparable counterpart increasingly reported among men.
Through TMS, Dr. McMullen will meet with afflicted patients and determine if TMS or Deep TMS is right for them. The specialists will determine the amount of electromagnetic impulse that will be most beneficial for the PGAD patient and will conduct the treatment for 20-40 minutes daily.
“TMS presents unmatched curing possibilities for a syndrome like PGAD today,” said Dr. McMullen. “After initial success, I am hoping to spread the word of this viable alternative for people struggling through life with this disorder.”
For more information, visit tmsbraincare.com.
For Immediate Release: June 9, 2017
Contact: Robert D. McMullen (212) 362-9635